AVEO Pharmaceuticals, Inc.
(NASDAQ : AVEO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.65%196.741.2%$490.07m
GILDGilead Sciences, Inc.
-0.91%71.680.9%$442.17m
BIIBBiogen Inc.
-0.10%315.231.3%$344.37m
ILMNIllumina, Inc.
-2.39%309.673.5%$333.23m
CELGCelgene Corporation
-1.17%79.671.2%$320.04m
VRTXVertex Pharmaceuticals Incorporated
-2.29%173.331.9%$230.84m
REGNRegeneron Pharmaceuticals, Inc.
-1.59%381.622.6%$220.41m
ALXNAlexion Pharmaceuticals, Inc.
-1.30%122.312.0%$215.29m
SRPTSarepta Therapeutics, Inc.
0.56%133.3016.4%$166.90m
AAgilent Technologies, Inc.
-3.30%62.161.5%$149.82m
BMRNBioMarin Pharmaceutical Inc.
-2.73%100.704.4%$135.57m
LGNDLigand Pharmaceuticals Incorporated
-2.33%180.5923.3%$115.45m
EXASExact Sciences Corporation
1.33%63.0825.3%$106.99m
ECYTEndocyte, Inc.
0.15%23.562.1%$96.01m
NBIXNeurocrine Biosciences, Inc.
-1.76%107.255.1%$94.01m

Company Profile

AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380, and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA.